businessneutralNovo Nordisk's New Weight-Loss Drug Fails to Impress InvestorsDenmarkFriday, December 20, 2024AdvertisementAdvertisementeuropefullereli lillyActionsflag contentPoorly writtenDuplicateInappropriateWrong locationBad formattingFalse InformationPotential Copyright/Trademark Violation